ALLARITY THERAPEUTICS, INC. (ALLR)
Clinical trial NCT05571969 updates: 1. status: SUSPENDED → TERMINATED 2. start date: 2023-02-20 → 2023-03-08 3. completion date: 2025-12-01 → 2024-10-07 4. primary completion date: 2024-10-01 → 2024-02-19 5. enrollment: 40 → 14 participants 6. enrollment type: ESTIMATED → ACTUAL 7. allocation: NA → NON_RANDOMIZED 8. intervention model: SINGLE_GROUP → SEQUENTIAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical